Comparative Safety and Changes in Immunologic and Virologic Parameters of Dolutegravir versus Efavirenz-Based Antiretroviral Therapies Among HIV Patients: A Retrospective Cohort Study.

Melese Alemnew AyalAlemseged Beyene Berha

Published in: HIV/AIDS (Auckland, N.Z.) (2023)

, OIs, and poor adherence with therapy were factors associated with poor survival and safety outcomes. HIV patients with these risk factors should be treated and monitored regularly.

Keyphrases

antiretroviral therapy
hiv infected
hiv positive
human immunodeficiency virus
hiv infected patients
hiv aids
risk factors
end stage renal disease
newly diagnosed
hiv testing
chronic kidney disease
ejection fraction
hepatitis c virus
prognostic factors
stem cells
south africa
insulin resistance
bone marrow